Your browser doesn't support javascript.
loading
Cold snare piecemeal EMR of large sessile colonic polyps ≥20 mm (with video).
Mangira, Dileep; Cameron, Karla; Simons, Koen; Zanati, Simon; LaNauze, Richard; Raftopoulos, Spiro; Brown, Gregor; Moss, Alan.
Afiliación
  • Mangira D; Department of Gastroenterology, Western Health, Melbourne, Australia; Department of Medicine, Western Health, Melbourne Medical School.
  • Cameron K; Department of Gastroenterology, Western Health, Melbourne, Australia.
  • Simons K; Western Health Office for Research, Western Health, Melbourne, St Albans, Australia; School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Zanati S; Department of Gastroenterology, Western Health, Melbourne, Australia.
  • LaNauze R; Department of Gastroenterology, Peninsula Health, Melbourne, Australia.
  • Raftopoulos S; Department of Gastroenterology, Sir Charles Gairdner Hospital, Perth, Australia.
  • Brown G; Department of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, Australia.
  • Moss A; Department of Gastroenterology, Western Health, Melbourne, Australia; Department of Medicine, Western Health, Melbourne Medical School.
Gastrointest Endosc ; 91(6): 1343-1352, 2020 06.
Article en En | MEDLINE | ID: mdl-31954132
BACKGROUND AND AIMS: Conventional EMR using a hot snare is the standard of care for resection of large (≥20 mm) nonmalignant sessile colonic polyps. Serious adverse events are predominantly because of electrocautery. This could potentially be avoided by cold snare piecemeal EMR (CSP-EMR). This study aimed to evaluate the safety and efficacy of CSP-EMR of sessile colonic polyps sized ≥20 mm. METHODS: All cases of CSP-EMR at 5 Australian academic hospitals for sessile polyps ≥20 mm over a 2-year period, from January 2016 to December 2017, were identified retrospectively. Efficacy was defined as the absence of residual or recurrent polyp tissue during the first surveillance colonoscopy (SC1) and second surveillance colonoscopy (SC2). Clinically significant intraprocedural or delayed adverse events and surveillance colonoscopy findings were assessed by reviewing medical records. RESULTS: CSP-EMR was performed on 204 polyps sized ≥20 mm in 186 patients (men, 33.8%; median age, 68 years). SC1 for 164 polyps (80.4%) at a median interval of 150 days showed residual or recurrent polyp in 9 cases (5.5%; 95% confidence interval, 3%-11%). SC2 for 113 polyps (72.9%) at a median interval of 18 months showed late residual or recurrent polyp in 4 cases (3.5%; 95% confidence interval, .9%-8.5%) after a normal SC1. Intraprocedural bleeding was successfully treated in 4 patients (2.2%), whereas 7 patients (3.8%) experienced self-limited clinically significant post-EMR bleeding and 1 patient (.5%) required overnight observation for nonspecific abdominal pain that resolved spontaneously. None experienced other adverse events. CONCLUSIONS: CSP-EMR of sessile colonic polyps ≥20 mm is technically feasible, effective, and safe. The adverse event rate and polyp recurrence rate were low. Randomized or large prospective trials are required to confirm the noninferiority and improved safety of CSP-EMR compared with conventional EMR and to further determine the polyp morphologies that are best suited for CSP-EMR.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pólipos del Colon Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Gastrointest Endosc Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pólipos del Colon Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Gastrointest Endosc Año: 2020 Tipo del documento: Article